Recurrent Rare Genomic Copy Number Variants and Bicuspid Aortic Valve Are Enriched in Early Onset Thoracic Aortic Aneurysms and Dissections

Siddharth Prakash, Shao-Qing Kuang, GenTAC Registry Investigators, Ellen Regalado, Dongchuan Guo, Dianna Milewicz, Williams Ravekes, Harry C Dietz, Kathryn W Holmes, Jennifer Habashi, Dianna M Milewicz, Siddharth K Prakash, Scott A LeMaire, Shaine A Morris, Cheryl L Maslen, Howard K Song, G Michael Silberbach, Reed E Pyeritz, Joseph E Bavaria, Karianna Milewski, Richard B Devereux, Jonathan W Weinsaft, Mary J Roman, Ralph Shohet, Nazli McDonnell, Federico M Asch, Kim A Eagle, H Eser Tolunay, Patrice Desvigne-Nickens, Hung Tseng, Barbara L Kroner, Siddharth Prakash, Shao-Qing Kuang, GenTAC Registry Investigators, Ellen Regalado, Dongchuan Guo, Dianna Milewicz, Williams Ravekes, Harry C Dietz, Kathryn W Holmes, Jennifer Habashi, Dianna M Milewicz, Siddharth K Prakash, Scott A LeMaire, Shaine A Morris, Cheryl L Maslen, Howard K Song, G Michael Silberbach, Reed E Pyeritz, Joseph E Bavaria, Karianna Milewski, Richard B Devereux, Jonathan W Weinsaft, Mary J Roman, Ralph Shohet, Nazli McDonnell, Federico M Asch, Kim A Eagle, H Eser Tolunay, Patrice Desvigne-Nickens, Hung Tseng, Barbara L Kroner

Abstract

Thoracic Aortic Aneurysms and Dissections (TAAD) are a major cause of death in the United States. The spectrum of TAAD ranges from genetic disorders, such as Marfan syndrome, to sporadic isolated disease of unknown cause. We hypothesized that genomic copy number variants (CNVs) contribute causally to early onset TAAD (ETAAD). We conducted a genome-wide SNP array analysis of ETAAD patients of European descent who were enrolled in the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC). Genotyping was performed on the Illumina Omni-Express platform, using PennCNV, Nexus and CNVPartition for CNV detection. ETAAD patients (n = 108, 100% European American, 28% female, average age 20 years, 55% with bicuspid aortic valves) were compared to 7013 dbGAP controls without a history of vascular disease using downsampled Omni 2.5 data. For comparison, 805 sporadic TAAD patients with late onset aortic disease (STAAD cohort) and 192 affected probands from families with at least two affected relatives (FTAAD cohort) from our institution were screened for additional CNVs at these loci with SNP arrays. We identified 47 recurrent CNV regions in the ETAAD, FTAAD and STAAD groups that were absent or extremely rare in controls. Nine rare CNVs that were either very large (>1 Mb) or shared by ETAAD and STAAD or FTAAD patients were also identified. Four rare CNVs involved genes that cause arterial aneurysms when mutated. The largest and most prevalent of the recurrent CNVs were at Xq28 (two duplications and two deletions) and 17q25.1 (three duplications). The percentage of individuals harboring rare CNVs was significantly greater in the ETAAD cohort (32%) than in the FTAAD (23%) or STAAD (17%) cohorts. We identified multiple loci affected by rare CNVs in one-third of ETAAD patients, confirming the genetic heterogeneity of TAAD. Alterations of candidate genes at these loci may contribute to the pathogenesis of TAAD.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. CNV Analysis Workflow.
Fig 1. CNV Analysis Workflow.

References

    1. Gillum RF (1995) Epidemiology of aortic aneurysm in the United States. J Clin Epidemiol 48: 1289–1298.
    1. Elefteriades JA (2008) Thoracic aortic aneurysm: reading the enemy’s playbook. Yale J Biol Med 81: 175–186.
    1. Milewicz DM, Chen H, Park ES, Petty EM, Zaghi H, Shashidhar G, et al. (1998) Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections. Am J Cardiol 82: 474–479.
    1. Milewicz DM, Guo DC, Tran-Fadulu V, Lafont AL, Papke CL, Inamoto S, et al. (2008) Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet 9: 283–302. 10.1146/annurev.genom.8.080706.092303
    1. Prakash SK, LeMaire SA, Guo DC, Russell L, Regalado ES, Golabbakhsh H, et al. (2010) Rare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissections. Am J Hum Genet 87: 743–756. 10.1016/j.ajhg.2010.09.015
    1. Schork NJ, Murray SS, Frazer KA, Topol EJ (2009) Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19: 212–219. 10.1016/j.gde.2009.04.010
    1. McBride KL, Zender GA, Fitzgerald-Butt SM, Koehler D, Menesses-Diaz A, Fernbach S, et al. (2009) Linkage analysis of left ventricular outflow tract malformations (aortic valve stenosis, coarctation of the aorta, and hypoplastic left heart syndrome). Eur J Hum Genet 17: 811–819. 10.1038/ejhg.2008.255
    1. Schaefer BM, Lewin MB, Stout KK, Gill E, Prueitt A, Byers PH, et al. (2008) The bicuspid aortic valve: an integrated phenotypic classification of leaflet morphology and aortic root shape. Heart 94: 1634–1638. 10.1136/hrt.2007.132092
    1. Beaton AZ, Nguyen T, Lai WW, Chatterjee S, Ramaswamy P, Lytrivi ID, et al. (2009) Relation of coarctation of the aorta to the occurrence of ascending aortic dilation in children and young adults with bicuspid aortic valves. Am J Cardiol 103: 266–270. 10.1016/j.amjcard.2008.09.062
    1. Tadros TM, Klein MD, Shapira OM (2009) Ascending aortic dilatation associated with bicuspid aortic valve: pathophysiology, molecular biology, and clinical implications. Circulation 119: 880–890. 10.1161/CIRCULATIONAHA.108.795401
    1. Singh R, Kolvraa S, Rattan SI (2007) Genetics of human longevity with emphasis on the relevance of HSP70 as candidate genes. Front Biosci 12: 4504–4513.
    1. Tomatsu S, Montaño AM, Ohashi A, Gutierrez MA, Oikawa H, Oguma T, et al. (2008) Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum Mol Genet 17: 815–824.
    1. Kameda Y (2009) Hoxa3 and signaling molecules involved in aortic arch patterning and remodeling. Cell Tissue Res 336: 165–178. 10.1007/s00441-009-0760-7
    1. Frieden LA, Townsend TA, Vaught DB, Delaughter DM, Hwang Y, Barnett JV, et al. (2010) Regulation of heart valve morphogenesis by Eph receptor ligand, ephrin-A1. Dev Dyn 239: 3226–3234. 10.1002/dvdy.22458
    1. Dykes IM, van Bueren KL, Ashmore RJ, Floss T, Wurst W, Szumska D, et al. (2014) HIC2 is a novel dosage-dependent regulator of cardiac development located within the distal 22q11 deletion syndrome region. Circ Res 115: 23–31. 10.1161/CIRCRESAHA.115.303300
    1. Jurecka A, Zakharova E, Cimbalistiene L, Gusina N, Kulpanovich A, Golda A, et al. (2013) Mucopolysaccharidosis type VI: a predominantly cardiac phenotype associated with homozygosity for p.R152W mutation in the ARSB gene. Am J Med Genet A 161A: 1291–1299. 10.1002/ajmg.a.35905
    1. Heegaard AM, Corsi A, Danielsen CC, Nielsen KL, Jorgensen HL, Riminucci M, et al. (2007) Biglycan deficiency causes spontaneous aortic dissection and rupture in mice. Circulation 115: 2731–2738.
    1. Costain G, Lionel AC, Merico D, Forsythe P, Russell K, Lowther C, et al. (2013) Pathogenic rare copy number variants in community-based schizophrenia suggest a potential role for clinical microarrays. Hum Mol Genet 22: 4485–4501. 10.1093/hmg/ddt297
    1. Hooli BV, Kovacs-Vajna ZM, Mullin K, Blumenthal MA, Mattheisen M, Zhang C, et al. (2014) Rare autosomal copy number variations in early-onset familial Alzheimer’s disease. Mol Psychiatry 19: 676–681. 10.1038/mp.2013.77
    1. Brandler WM, Sebat J (2015) From de novo mutations to personalized therapeutic interventions in autism. Annu Rev Med 66: 487–507. 10.1146/annurev-med-091113-024550
    1. Wheeler E, Huang N, Bochukova EG, Keogh JM, Lindsay S, Garg S, et al. (2013) Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity. Nat Genet 45: 513–517. 10.1038/ng.2607
    1. Prakash SK, Bosse Y, Muehlschlegel JD, Michelena HI, Limongelli G, Della Corte A, et al. (2014) A roadmap to investigate the genetic basis of bicuspid aortic valve and its complications: insights from the International BAVCon (Bicuspid Aortic Valve Consortium). J Am Coll Cardiol 64: 832–839.
    1. Michelena HI, Desjardins VA, Avierinos JF, Russo A, Nkomo VT, Sundt TM, et al. (2008) Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation 117: 2776–2784. 10.1161/CIRCULATIONAHA.107.740878
    1. Januzzi JL, Isselbacher EM, Fattori R, Cooper JV, Smith DE, Fang J, et al. (2004) Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol 43: 665–669.
    1. Carlson M, Airhart N, Lopez L, Silberbach M (2012) Moderate aortic enlargement and bicuspid aortic valve are associated with aortic dissection in Turner syndrome: report of the international turner syndrome aortic dissection registry. Circulation 126: 2220–2226. 10.1161/CIRCULATIONAHA.111.088633
    1. McBride KL, Zender GA, Fitzgerald-Butt SM, Seagraves NJ, Fernbach SD, Zapata G, et al. (2011) Association of common variants in ERBB4 with congenital left ventricular outflow tract obstruction defects. Birth Defects Res A Clin Mol Teratol 91: 162–168. 10.1002/bdra.20764
    1. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, et al. (2007) PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 17: 1665–1674.
    1. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559–575.
    1. Raychaudhuri S, Korn JM, McCarroll SA, Altshuler D, Sklar P, Purcell S, et al. (2010) Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS genetics 6:
    1. Chen J, Xu H, Aronow BJ, Jegga AG (2007) Improved human disease candidate gene prioritization using mouse phenotype. BMC Bioinformatics 8: 392
    1. Weaver S, Dube S, Mir A, Qin J, Sun G, Ramakrishnan R, et al. (2010) Taking qPCR to a higher level: Analysis of CNV reveals the power of high throughput qPCR to enhance quantitative resolution. Methods 50: 271–276. 10.1016/j.ymeth.2010.01.003
    1. Hoebeeck J, van der Luijt R, Poppe B, De Smet E, Yigit N, Claes K, et al. (2005) Rapid detection of VHL exon deletions using real-time quantitative PCR. Lab Invest 85: 24–33.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj